Low molecular weight heparin-induced thrombocytopenia and thrombosis.
Peters
F P
FP
Doevendans
P A
PA
Erdkamp
F L
FL
Van Der Ent
F W
FW
De Heer
F
F
D000230:Adenocarcinoma / Q000601:surgery*; D000368:Aged; D001157:Arterial Occlusive Diseases / Q000139:chemically induced; D001241:Aspirin / Q000627:therapeutic use; D003911:Dextrans / Q000627:therapeutic use; D004617:Embolism / Q000139:chemically induced / Q000601:surgery; D005260:Female; D005263:Femoral Artery; D006493:Heparin; D006495:Heparin, Low-Molecular-Weight / Q000009:adverse effects*; D006801:Humans; D007680:Kidney Neoplasms / Q000601:surgery*; D009203:Myocardial Infarction / Q000139:chemically induced; D009392:Nephrectomy; D010976:Platelet Count / Q000187:drug effects; D011183:Postoperative Complications / Q000517:prevention & control; D013921:Thrombocytopenia / Q000139:chemically induced* / Q000188:drug therapy; D013927:Thrombosis / Q000139:chemically induced* / Q000517:prevention & control
D003911:Dextrans; D006495:Heparin, Low-Molecular-Weight; D006493:Heparin; D001241:Aspirin